Mutares SE & Co. KGaA reported strong Q3 2026 results, with holding net income of EUR 33 million and group revenue around EUR 5.4 billion. The company is on track to meet its goal of EUR 100 million in consulting revenues annually, showing flat growth in Europe but significant expansion in the U.S. Mutares plans to continue hiring in America to support this growth and expects 25% year-over-year revenue growth through 2030, signaling a record year ahead.
Mutares SE & Co. KGaA's Q3 2026 earnings provide context for readers following Industrials-sector stocks. For readers following Industrials, here is Pluang's market snapshot as of Nov 12, 2026 23:11 WIB: Among 135 priced US Industrials stocks, 77 rose and 58 fell. GE Vernova Inc (GEV) gained 3.68% to USD 838.00 with a typical hold time of 43 days, contrasting with Virgin Galactic Holdings (SPCE) which fell 4.18% to USD 2.75 and saw 97% sell orders. Vertiv Holdings Co (VRT) rose 3.37% to USD 213.46 with nearly balanced buy-sell activity.
D.A. Davidson raised Riskified's price target to $12, reflecting a 22.2% potential upside from $9.82. The company reported a 41% revenue increase to $115.2 million and adjusted earnings of $0.07 per share, beating estimates. Profitability improved wi...
TRM Labs introduced the Disruption Awards to recognize coalitions of public and private organizations that successfully disrupted major cybercrimes in 2026. Winners include groups that took down a phishing service responsible for most Microsoft-block...
Existing-home sales in the U.S. dropped 5.5% month-over-month and 8.8% year-over-year in October, reaching the lowest level since August 2010. The decline is attributed to mortgage rates rising to their highest since 2000, making home buying more dif...
The global specialty zeolites market, valued at $1 million in 2025, is projected to reach $1.5 million by 2032 with a 5.8% CAGR. Growth is fueled by stricter environmental regulations and rising demand in water treatment, petrochemicals, agriculture,...
The global cell lysis and cell fractionation market, valued at $2.8 billion in 2025, is projected to grow to $4.5 billion by 2032 at a 7% CAGR. Growth is fueled by advances in biotechnology, increased life sciences research investments, and rising de...
